Stem Cell Therapy International completes merger with Histostem of South Korea (News-Medical-Net) Stem Cell Therapy International, Inc. announced that it has completed its merger with Histostem Ltd. of South Korea ("Histostem"), forming one of the first fully merged Pacific Rim stem cell companies and cord blood repositories with a U.S. entity. [News Source]